Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB04892> ?p ?o ?g. }
Showing items 1 to 16 of
16
with 100 items per page.
- drugbank:DB04892 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04892 label "Phenserine [drugbank:DB04892]" assertion.
- drugbank:DB04892 seeAlso DB04892 assertion.
- drugbank:DB04892 identifier "drugbank:DB04892" assertion.
- drugbank:DB04892 description "Phenserine is under development by Axonyx, a US biopharmaceutical company that focuses on treatments for dementia. Phenserine is a next generation acetylcholinesterase (AChE) inhibitor indicated for the treatment of AD. Unlike currently marketed AChE inhibitors, it has a dual mechanism of action that also includes anti-amyloid activity, which may confer disease-modifying effects in patients with AD. If this is substantiated in an ongoing clinical trial then phenserine may open the door to an entirely new type of treatment for AD. Axonyx announced on 20 September 2005 that phenserine was ineffective in two curtailed phase 3 trials." assertion.
- drugbank:DB04892 title "Phenserine" assertion.
- drugbank:DB04892 bio2rdf_vocabulary:identifier "DB04892" assertion.
- drugbank:DB04892 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04892 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04892" assertion.
- drugbank:DB04892 bio2rdf_vocabulary:x-identifiers.org DB04892 assertion.
- drugbank:DB04892 drugbank_vocabulary:drugbank-id "DB04892" assertion.
- drugbank:DB04892 drugbank_vocabulary:x-cas cas:101246-66-6 assertion.
- drugbank:DB04892 drugbank_vocabulary:x-chemspider chemspider:167225 assertion.
- drugbank:DB04892 drugbank_vocabulary:x-pubchemcompound pubchem.compound:192706 assertion.
- drugbank:DB04892 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:14900124 assertion.
- drugbank:DB04892 drugbank_vocabulary:x-bindingdb bindingdb:10958 assertion.